![Circulating microRNAs as putative mediators in the association between short-term exposure to ambient air pollution and cardiovascular biomarkers - ScienceDirect Circulating microRNAs as putative mediators in the association between short-term exposure to ambient air pollution and cardiovascular biomarkers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0147651322004444-gr4.jpg)
Circulating microRNAs as putative mediators in the association between short-term exposure to ambient air pollution and cardiovascular biomarkers - ScienceDirect
![Frontiers | miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential Frontiers | miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential](https://www.frontiersin.org/files/Articles/949566/fphar-13-949566-HTML/image_m/fphar-13-949566-g001.jpg)
Frontiers | miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
![Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer - Lung Cancer Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4d7780aa-be93-4180-a571-051133037f75/gr1.jpg)
Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer - Lung Cancer
![Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy - Lung Cancer Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2d4d7f76-7799-4e63-a95a-c030b8d47ae2/gr1_lrg.jpg)
Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy - Lung Cancer
![Frontiers | A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab Frontiers | A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab](https://www.frontiersin.org/files/Articles/606027/fimmu-12-606027-HTML/image_m/fimmu-12-606027-g001.jpg)
Frontiers | A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab
![Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378874120336588-fx1.jpg)
Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect
![Concepts, Considerations, and Concerns on the Cutting Edge of Radiofrequency Ablation - Journal of Vascular and Interventional Radiology Concepts, Considerations, and Concerns on the Cutting Edge of Radiofrequency Ablation - Journal of Vascular and Interventional Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/809428/5915611/gr1.jpg)
Concepts, Considerations, and Concerns on the Cutting Edge of Radiofrequency Ablation - Journal of Vascular and Interventional Radiology
![MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3db92b6b-2a33-41ea-9828-3bf737000a3b/gr3_lrg.jpg)
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports
![Intravoxel Incoherent Motion Diffusion‐Weighted Imaging for Predicting and Monitoring the Response of Anti‐Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma - Wan - 2022 - Journal of Magnetic Resonance Intravoxel Incoherent Motion Diffusion‐Weighted Imaging for Predicting and Monitoring the Response of Anti‐Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma - Wan - 2022 - Journal of Magnetic Resonance](https://onlinelibrary.wiley.com/cms/asset/31dfb1a1-b51c-4cde-9d5e-94576bf5c437/jmri.v55.4.cover.jpg?trick=1663369010306)
Intravoxel Incoherent Motion Diffusion‐Weighted Imaging for Predicting and Monitoring the Response of Anti‐Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma - Wan - 2022 - Journal of Magnetic Resonance
![Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378874120336588-gr1.jpg)
Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect
![MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/28d1f47b-5a6e-4ee2-9f76-82a2a67b2c1f/gr4_lrg.jpg)